Overview
Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety
Status:
Completed
Completed
Trial end date:
2009-04-01
2009-04-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to evaluate the long-term pulmonary and cardiovascular safety of Exubera in routine clinical practice.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
PfizerTreatments:
Insulin
Insulin, Globin Zinc
Criteria
Inclusion Criteria:- Eligible for receiving Exubera treatment based on the approved local label
Exclusion Criteria:
- Pregnant or lactating
- Have a progressive fatal disease or a life expectancy that prohibits them from
participating in a five-year research study